Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1215 of 6351
-
New heart valve offers hope for High-Risk chinese patients
Disease control CompletedTo evaluate the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic severe calcific aortic stenosis who are considered at high risk for surgical valve replacement.
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 26, 2026 16:50 UTC
-
Can diet and exercise slow prostate Cancer's return after surgery?
Disease control OngoingThe Prostate 8-II study is a randomized controlled trial of testing different combinations of educational and supportive tools related to diet and exercise to evaluate biological, clinical, and quality of life outcomes in men choosing radical prostatectomy as treatment for prosta…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Bionic eye implant aims to restore sight in dry AMD patients
Disease control CompletedIn this early feasibility trial the safety and performance of the new retinal prothesis PRIMA is tested in five subjects suffering from atrophic dry age related macular degeneration.
Sponsor: Science Corporation • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New tethering technique may offer Motion-Sparing alternative to spinal fusion for kids with scoliosis
Disease control By invitation onlyThe Researchers want to assess the short-term safety of Anterior Vertebral Body Tethering (AVBT) in skeletally immature subjects with moderate to severe scoliosis and compare them with a fusion cohort.
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Should asymptomatic heart valve patients get surgery now? major trial aims to settle debate
Disease control Recruiting nowDegenerative mitral regurgitation (MR) due to leaflet prolapse is frequent and can be surgically repaired in the vast majority of patients. Despite the efficacy of mitral valve repair, an ongoing international controversy exists regarding the need to perform early surgery in asym…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New prostate surgery technique aims to save erections and bladder control
Symptom relief OngoingIn summary this trial will test whether this new surgical technique can be used to make surgery safer and more effective whilst allowing improved quality of life for patients having surgery for prostate cancer. If the technique is proven effective the investigators will use the e…
Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 26, 2026 13:54 UTC
-
New hope for kids with hodgkin lymphoma: modified chemo regimen tested in china
Disease control OngoingThe incidence of Hodgkin's lymphoma (HL) in Chinese children and adolescents is only 1 / 10 of that in Europe and the United States, which is a "rare" childhood tumor. Due to the "drug shortage" and extremely low incidence, it has brought great difficulties to the domestic clinic…
Phase 4 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Precision lead placement could boost heart failure device success
Disease control CompletedHeart failure is a leading cause of morbidity and mortality. Cardiac resynchronization therapy (CRT) is a well-established treatment for patients with symptomatic heart failure in spite of optimised medical treatment (OMT), reduced left ventricular pump function with left ventric…
Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a pill tame a common blood cancer in the real world?
Disease control CompletedThis study will evaluate real-life effectiveness and use in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).
Sponsor: AbbVie • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
C-Section bleeding breakthrough: tranexamic acid tested on 4,500 women
Disease control CompletedThe aim is to assess the impact of tranexamic acid (TXA) for preventing postpartum hemorrhage (PPH) following a cesarean section (CS).
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could an ancient herb ease Chemo's worst side effects?
Symptom relief CompletedAdjuvant chemotherapy usually is recommended after surgery for breast cancer patients who are at significant risk for disseminated disease. Chemotherapy has been demonstrated to reduce the risk of breast cancer recurrence. Anthracycline-based regimens, including doxorubin or epil…
Phase 2 • Sponsor: PhytoHealth Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Tailored radiation blasts brain tumors where They're most likely to return
Disease control CompletedThe study is a pilot study to estimate the efficacy of personalized dose-escalation radiation therapy in patients with glioblastoma, as measured by estimating the median of progression-free survival. Toxicity, patterns of recurrence, and overall median survival will be measured a…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
One-Time gene therapy shot aims to ease severe hemophilia a
Disease control CompletedThe main aim of this study is to check if there are side effects from BAX 888 and to determine the dose of BAX 888 for treating severe hemophilia A in male adults. Participants will receive one infusion with BAX 888 at the hemophilia treatment center. During the study, participa…
Phase 1/2 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated Jun 26, 2026 16:52 UTC
-
Could a nasal spray boost social skills in kids with autism?
Symptom relief CompletedThe purpose of this clinical trial is to investigate the effectiveness of vasopressin nasal spray for treating symptoms associated with autism. Vasopressin is a hormone that is produced naturally within the body and has been implicated in regulating social behaviors. It has been …
Phase 2/3 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New hope for kidney disease: early combo therapy may slow IgA nephropathy
Disease control CompletedTIGER study (Treatment of IgA nEphropathy according to Renal lesions) is a prospective openly randomized controlled study. The main objective is to evaluate the efficacy of early corticotherapy + Renin Angiotensin System (RAS) blockade or inhibitors of Sodium glucose transporter…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Drug combo aims to boost lung cancer treatment
Disease control OngoingThis research study is studying a combination of two targeted therapies as a possible treatment for Non-Small Cell Lung Cancer (NSCLC) with an EGFR mutation. The drugs involved in this study are: * Osimertinib (Tagrisso) * Selumetinib
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug aims to stop relapses in rare brain disease
Disease control Stopped earlyThe purpose of this study is to initially observe the safety and effectivity of RC18 in Participants with Neuromyelitis Optica Spectrum Disorders.
Phase 3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Gene therapy trial for duchenne MD halted early – what we know
Disease control Stopped earlyThis is a first-in-human/first-in-patient, multi-center, open-label, non-randomized, ascending dose, safety and tolerability study of a single intravenous infusion of PF-06939926 in ambulatory and non-ambulatory subjects with Duchenne muscular dystrophy (DMD). Other objectives in…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 26, 2026 17:12 UTC
-
Could stem cells slow Huntington's? new trial tests cellavita HD
Disease control CompletedCellavita HD is a stem-cell therapy for Huntington's Disease. This is a prospective, phase II, single-center, randomized (2:2:1), triple-blind, placebo controlled study, with two test doses of Cellavita HD product.
Phase 2 • Sponsor: Azidus Brasil • Aim: Disease control
Last updated Jun 26, 2026 18:55 UTC
-
Laser rejuvenation may shield aging skin from cancer
Disease control Recruiting nowThis study is following up on previous studies that have demonstrated that geriatric subjects respond different to ultraviolet B (UVB) light than young subjects. The treatment of geriatric skin with dermal rejuvenation therapies (dermabrasion, fractionated laser resurfacing) rest…
Sponsor: Wright State University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC